Dr. Gillett & James O'Hara discuss the FDA ruling on MDMA. 00:00 Intro01:10 FDA's decision on MDMA therapy is pending, with possibilities ranging from approval. 06:00 MDMA affects various hormones post-consumption, including serotonin and cortisol, potentially impacting mood and physiology.09:30 MDMA trials for PTSD 14:55 Concerns over MDMA trials 21:32 FDA critiques MDMA therapy training protocols for therapists to prevent abuse. 24:33 MDMA is considered safer compared to benzodiazepines in certain respects. 27:33 Balancing drug accessibility and safety through regulatory measures is crucial to advancing scientific research and ensuring public health.29:30 OutroStudies/References:► https://sci-hub.se/https://pubmed.ncbi.nlm.nih.gov/31734398/► https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205851/► https://www.nature.com/articles/s41591-023-02565-4► https://abcnews.go.com/Health/fda-advisers-recommending-mdma-treatment-ptsd/story?id=110808948For High-Quality Labs:► https://gilletthealth.com/order-lab-panels/For information on the Gillett Health clinic, lab panels, and health coaching:► https://GillettHealth.comFollow Gillett Health for more content from James and Kyle► https://instagram.com/gilletthealth► https://www.tiktok.com/@gilletthealth► https://twitter.com/gilletthealth► https://www.facebook.com/gilletthealthFollow Kyle Gillett, MD► https://instagram.com/kylegillettmdFollow James O’Hara, NP► https://Instagram.com/jamesoharanpFor 10% off Gorilla Mind products including SIGMA: Use code “GH10”► https://gorillamind.com/For discounts on high-quality supplements►https://www.thorne.com/u/GillettHealth#ptsd #fda #podcastAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Ver todos los episodios